SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (263)4/30/2002 1:19:03 PM
From: nigel bates  Respond to of 625
 
It's not a break up fee.
When they originally bid for DRC, the two companies agreed that if the bid did not succeed, CAT would have the right to repurchase the royalty rights DRC held with respect to CAT's products. This they have now done.

nig